atenolol has been researched along with Coronary Occlusion in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, K | 1 |
| Saito, N | 1 |
| Zhang, G | 1 |
| Conditt, G | 1 |
| McGregor, J | 1 |
| Flynn, AM | 1 |
| Leahy, D | 1 |
| Glennon, P | 1 |
| Leon, MB | 1 |
| Hayase, M | 1 |
1 other study available for atenolol and Coronary Occlusion
| Article | Year |
|---|---|
Development of a novel calcified total occlusion model in porcine coronary arteries.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Calcinosis; Coronary Angiography; Coronary Occlusion | 2008 |